Drug Information

Drug General Information
Drug ID
D0C8IB
Former ID
DNC010645
Drug Name
(R)-3-(1H-imidazol-4-yl)propyl sec-butylcarbamate
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530465]
Formula
C11H19N3O2
Canonical SMILES
CCC(C)NC(=O)OCCCC1=CN=CN1
InChI
1S/C11H19N3O2/c1-3-9(2)14-11(15)16-6-4-5-10-7-12-8-13-10/h7-9H,3-6H2,1-2H3,(H,12,13)(H,14,15)/t9-/m1/s1
InChIKey
RSHJCGZZSGNBHO-SECBINFHSA-N
PubChem Compound ID
10680721
Target and Pathway
Target(s) Histamine H3 receptor Target Info Inhibitor [530465]
Histamine H4 receptor Target Info Inhibitor [530465]
KEGG Pathway Neuroactive ligand-receptor interactionhsa04080:Neuroactive ligand-receptor interaction
Reactome Histamine receptors
G alpha (i) signalling eventsR-HSA-390650:Histamine receptors
G alpha (i) signalling events
WikiPathways Monoamine Transport
GPCRs, Class A Rhodopsin-like
GPCR ligand binding
GPCR downstream signalingWP1825:GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 530465Bioorg Med Chem Lett. 2009 Dec 1;19(23):6682-5. Epub 2009 Oct 6.Histamine H3 and H4 receptor affinity of branched 3-(1H-imidazol-4-yl)propyl N-alkylcarbamates.
Ref 530465Bioorg Med Chem Lett. 2009 Dec 1;19(23):6682-5. Epub 2009 Oct 6.Histamine H3 and H4 receptor affinity of branched 3-(1H-imidazol-4-yl)propyl N-alkylcarbamates.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.